19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Medications
Resources
Basic InformationLatest News
Many Cases of 'Penicillin Allergy' Might Be MistakenCOVID Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker SaysHigh Costs Lead Millions of Americans to Shop Abroad for Rx DrugsFDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19How Ritalin Works in the BrainFDA Pulls Heartburn Drug Zantac From MarketTaking More Antibiotics May Up Odds for HospitalizationAllergy Med Singulair to Get 'Black Box' Warning Over Psych Side Effects: FDAU.S. Drug Prices Have Risen Three Times Faster Than InflationUse Pot? It Can Interact With Your Meds in Harmful WaysToo Many Antibiotics, Opioids Given to Dental Patients in the ERBrand-Name Rx Rise After Docs Get Drug Company Perks: StudyAs Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go WithoutPrice Hikes Have Patients Turning to Craigslist for Insulin, Asthma InhalersAI May Help Guide Patients to Most Effective Antidepressant1 in 4 Gets Unneeded Antibiotics at Children's HospitalsStudy Finds 'No Clear Rationale' for 45% of Antibiotic PrescriptionsAre Antibiotics a Recipe for Obesity in Childhood?Do You Take Warfarin? Time of Day Might Not MatterNew Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?Health Tip: Acetaminophen SafetyTwo More Heartburn Meds Recalled Due to Possible CarcinogenMany Drugstores Misinform on Disposal of Unused MedsHealth Tip: How to Remember to Take Your MedicationsFDA to Allow States to Import Prescription Drugs From Other CountriesOver 40% of Antibiotics Could Be 'Inappropriately' PrescribedFDA Testing Levels of Carcinogen in Diabetes Drug MetforminTaking Several Prescription Drugs May Trigger Serious Side EffectsPenicillin Allergy Less Common Than Thought: StudyMany Older Americans Misuse Antibiotics: PollAntibiotics Not Recommended for Most Toothaches, New Guideline SaysHealth Tip: Taking Anti-Inflammatory DrugsMany Common Meds Could Alter Your MicrobiomeWhen Meds Are Free, Patients Take Them More OftenMaker Halts Distribution of Generic Zantac Due to Possible CarcinogenKids Often Prescribed Drugs 'Off-Label,' Raising ConcernsHeartburn Drug Zantac May Contain Small Amounts of Known Carcinogen, FDA SaysHealth Tip: Take Over-the-Counter Medication WiselyA Prescription for Medicating Your Child SafelyHealth Tip: Taking Dietary SupplementsTrump Administration Announces Plan to Allow Cheaper Drug Imports From CanadaAre Too Many Kids Prescribed Antihistamines?Some Meds and Driving a Dangerous DuoHigher Cost of New Cholesterol Drugs Putting Patients at Risk: StudyMany Americans Take Antibiotics Without a PrescriptionHealth Tip: Packing Prescriptions for Travel
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

FDA to Allow States to Import Prescription Drugs From Other Countries

HealthDay News
by By Dennis Thompson
HealthDay Reporter
Updated: Dec 18th 2019

new article illustration

WEDNESDAY, Dec. 18, 2019 (HealthDay News) -- Federal health officials have unveiled plans to allow prescription drug imports from Canada and other foreign nations.

The U.S. Food and Drug Administration is proposing a rule under which states could import some prescription drugs from Canada, U.S. Health and Human Services Secretary Alex Azar announced Tuesday.

The agency also plans to make it easier for drug manufacturers to import their own FDA-approved drugs that are manufactured abroad and intended for sale in other countries.

"This would potentially allow for the sale of these drugs at lower prices than currently offered to American consumers, giving drug makers new flexibility to reduce list prices," Azar told reporters.

Azar touted the proposals as "historic."

All imported drugs would have to be FDA-approved, tested to ensure quality, and relabeled to meet U.S. labeling requirements, added Admiral Brett Giroir, the assistant secretary for health.

State programs created to import medications would be limited to pills that patients would typically get from a pharmacy, Azar said. Injectable products, controlled substances, biologic products and intravenous drugs would not be allowed.

States would create these programs, possibly in conjunction with wholesalers or pharmacies, and then submit them to FDA for approval, Giroir said.

However, drug manufacturers would be able to import any of their own products from other foreign countries, Azar said. That would include products such as insulin, which has recently been subject to steep price hikes.

"Every product is available for importation from every country by a manufacturer," Azar said. "There is no restriction there, if a manufacturer is willing."

The manufacturer pathway is intended to address the "bizarre" system of drug rebates that some pharmaceutical companies have blamed for high prices, Azar said.

"Even if the drug company would like to lower the list price of their drug, they may actually be precluded from doing so because of their arrangements with these middle men, where they have to funnel a certain amount of rebate money to those middle men," Azar said.

Drug companies have said if they can get a new National Drug Code for an imported version of the exact same medicine, then they would compete against their own products at a lower list price, Azar said.

The new proposals are only aimed at brand-name drugs, Giroir said.

"The draft guidance does not address generic drugs because we are not aware of similar private market challenges for reducing the cost of generic drugs," Giroir said.

The FDA is open to considering similar proposals for generic if warranted, he added.

The officials could not say how soon patients will benefit from these proposals, but said that the manufacturer's guidance will likely move faster because it faces fewer regulatory hurdles.

More information

There's more on the rising costs off prescription medicines at Consumer Reports.